# Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD

> **NCT02206776** · PHASE2 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 2 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** Intranasal Ketamine
- **DRUG:** Intranasal Midazolam

## Key facts

- **NCT ID:** NCT02206776
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** poor tolerability and low enrollment rate
- **Last updated:** 2017-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02206776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02206776, "Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02206776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*